Altrinsic Global Advisors’s Kura Oncology KURA Stock Holding History

Altrinsic Global Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-110,000	Closed	-$1.54M	–	64
2021 Q4	$1.54M	Hold	110,000	–	–	0.05%	64
2021 Q3	$2.06M	Buy	110,000 +20,000	+22%	+$377K	0.06%	63
2021 Q2	$1.88M	Buy	90,000 +20,000	+29%	+$497K	0.06%	67
2021 Q1	$1.98M	Sell	70,000 -5,000	-7%	-$158K	0.06%	68
2020 Q4	$2.45M	Sell	75,000 -25,000	-25%	-$878K	0.08%	57
2020 Q3	$3.06M	Sell	100,000 -10,000	-9%	-$221K	0.13%	48
2020 Q2	$1.79M	Hold	110,000	–	–	0.08%	57
2020 Q1	$1.09M	Buy	110,000 +20,000	+22%	+$229K	0.06%	66
2019 Q4	$1.24M	Hold	90,000	–	–	0.05%	63
2019 Q3	$1.36M	Sell	90,000 -5,000	-5%	-$89K	0.06%	61
2019 Q2	$1.87M	Sell	95,000 -10,000	-10%	-$166K	0.09%	56
2019 Q1	$1.74M	Hold	105,000	–	–	0.08%	62
2018 Q4	$1.47M	Buy	105,000 +25,000	+31%	+$331K	0.07%	62
2018 Q3	$1.4M	Hold	80,000	–	–	0.06%	68
2018 Q2	$1.46M	Hold	80,000	–	–	0.06%	67
2018 Q1	$1.5M	Buy	80,000 +20,000	+33%	+$389K	0.06%	67
2017 Q4	$918K	Hold	60,000	–	–	0.04%	73
2017 Q3	$897K	Buy	+60,000	New	+$563K	0.03%	76

Other funds holding KURA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Altrinsic Global Advisors's KURA Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 110,000 shares — an estimated $1.54M sold.

Altrinsic Global Advisors first reported a position in KURA in Q3 2017 and held it in 18 quarters. The position peaked at $3.06M in Q3 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

Altrinsic Global Advisors reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
Altrinsic Global Advisors sold 110,000 Kura Oncology shares in Q1 2022, an estimated $1.54M.
Altrinsic Global Advisors first reported a position in Kura Oncology in Q3 2017 and held it in 18 quarters.
Altrinsic Global Advisors's Kura Oncology position peaked at $3.06M in Q3 2020.
152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.